GSK

GlaxoSmithKline consolidates Pfizer consumer brands under Publicis Media specialty unit
Fierce Pharma
Sun, 01/5/20 - 07:08 pm
GSK
consumer health
Publicis Media
GSK closes sale of two vaccine brands to Bavarian Nordic
Pharmaceutical Business Review
Thu, 01/2/20 - 10:49 am
GSK
vaccines
Bavarian Nordic
Rabipur
Encepur
travel vaccines
FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
Endpoints
Mon, 12/23/19 - 11:44 pm
FDA
complete response letter
GSK
HIV
cabotegravir
rilpivirine
Is there a future for pharma in neuro?
Fierce Biotech
Sun, 12/22/19 - 12:25 am
Neuroscience
R&D
Eli Lilly
Amgen
GSK
Novartis
GSK finds synergies with global marketing strategy
Pharmaforum
Fri, 12/20/19 - 10:18 am
GSK
Drugmakers rebranding around oncology, rare diseases could provide 2020 preview
Fierce Pharma
Thu, 12/19/19 - 11:32 pm
oncology
Rare Diseases
AstraZeneca
GSK
Alexion
Takeda
Soliris
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
Thu, 12/19/19 - 01:05 pm
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win
Fierce Pharma
Wed, 12/18/19 - 10:54 am
GSK
Benlysta
lupus
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Tue, 12/17/19 - 10:34 am
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche
GSK poised to leap back into the oncology market with more positive belantamab mafodotin results — but BCMA rivals are swarming in behind
Endpoints
Mon, 12/16/19 - 10:39 pm
GSK
Multiple Myeloma
belantamab mafodotin
clinical trials
GSK's ViiV seeks marketing license for baby-friendly HIV pill
Reuters
Sun, 12/15/19 - 12:23 am
GSK
HIV
Dolutegravir
pediatric
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Hikma
FDA
generics
GSK
Advair
asthma
COPD
AI's impact in drug discovery is coming fast, predicts GSK's Hal Barron
Biopharma Dive
Thu, 11/21/19 - 06:27 pm
R&D
drug discovery
machine learning
artificial intelligence
GSK
Hal Barron
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
GlaxoSmithKline's Shingrix supply will vault upward, CEO says—in 2024, that is
Fierce Pharma
Fri, 11/15/19 - 10:45 am
GSK
vaccines
drug shortages
Shingrix
shingles
Nucala works in rare inflammatory disease, says GSK
PM Live
Wed, 11/13/19 - 09:55 am
GSK
clinical trials
Nucala
hypereosinophilic syndromes
HES
GSK must continue to improve R&D, says CEO Walmsley
Pharmaforum
Tue, 11/12/19 - 10:07 am
GSK
R&D
Emma Walmsley
Pharma CEOs
Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo
Fierce Pharma
Thu, 11/7/19 - 10:21 am
China
AstraZeneca
Roche
Sanofi
GSK
GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab
Fierce Pharma
Wed, 10/30/19 - 11:07 pm
GSK
Trelegy Ellipta
COPD

Pages